Пређи на садржај

Онкологија (педијатрија)

Ризици трансфузије и дилеме

The contribution of multiple packed red blood cell transfusions toward cardiac and liver dysfunction in pediatric patients with acute myeloid leukemia. (отвара нови прозор)

Al-Darwish M, Farhan N, Al-Jebreen A, Allam R, Al-Ahmari A, Seraihy A, Al-Sweedan S, El-Solh H, Belgaumi AF

Извор‎: Leuk Lymphoma 2016;57(10):2472-5.

Индекс‎: PubMed 26916606

DOI‎: 10.3109/10428194.2016.1151509

https://www.ncbi.nlm.nih.gov/pubmed/26916606 (отвара нови прозор)

Indications for and adverse effects of red-cell transfusion. (отвара нови прозор)

Carson JL, Triulzi DJ, Ness PM

Извор‎: N Engl J Med 2017;377(13):1261-72.

Индекс‎: PubMed 28953438

DOI‎: 10.1056/NEJMra1612789

https://www.ncbi.nlm.nih.gov/pubmed/28953438 (отвара нови прозор)

Blood product transfusions and clinical outcomes in pediatric patients with acute lung injury. (отвара нови прозор)

Church GD, Matthay MA, Liu K, Milet M, Flori HR.

Извор‎: Pediatr Crit Care Med 2009;10(3):297-302.

Индекс‎: PubMed 19307809

DOI‎: 10.1097/PCC.0b013e3181988952

https://www.ncbi.nlm.nih.gov/pubmed/19307809 (отвара нови прозор)

Severe thrombocytopenia in a child secondary to passive platelet antibody transfer from a plasma transfusion. (отвара нови прозор)

Collins CL, Scott JP, Panepinto JA, Punzalan RC

Извор‎: J Pediatr Hematol Oncol 2013;35(5):e226-8.

Индекс‎: PubMed 23459377

DOI‎: 10.1097/MPH.0b013e3182830c25

https://www.ncbi.nlm.nih.gov/pubmed/23459377 (отвара нови прозор)

Clinical outcomes associated with RBC transfusions in critically ill children: a 1-year prospective study. (отвара нови прозор)

Demaret P, Tucci M, Karam O, Trottier H, Ducruet T, Lacroix J.

Извор‎: Pediatr Crit Care Med 2015;16(6):505-14.

Индекс‎: PubMed 25905491

DOI‎: 10.1097/PCC.0000000000000423

https://www.ncbi.nlm.nih.gov/pubmed/25905491 (отвара нови прозор)

Platelet transfusions in pediatric intensive care. (отвара нови прозор)

Du Pont-Thibodeau G, Tucci M, Robitaille N, Ducruet T, Lacroix J

Извор‎: Pediatr Crit Care Med 2016;17(9):e420-9.

Индекс‎: PubMed 27472254

DOI‎: 10.1097/PCC.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/27472254 (отвара нови прозор)

Serious hazards of transfusion in children (SHOT). (отвара нови прозор)

Harrison E, Bolton P.

Извор‎: Paediatr Anaesth 2011;21(1):10-3.

Индекс‎: PubMed 21155922

DOI‎: 10.1111/j.1460-9592.2010.03474.x

https://www.ncbi.nlm.nih.gov/pubmed/21155922 (отвара нови прозор)

Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? (отвара нови прозор)

Jaime-Pérez JC, Colunga-Pedraza PR, Gómez-Almaguer D

Извор‎: Pediatr Blood Cancer 2011;57(2):217-23.

Индекс‎: PubMed 21671359

DOI‎: 10.1002/pbc.22957

https://www.ncbi.nlm.nih.gov/pubmed/21671359 (отвара нови прозор)

The risk of transfusion-transmitted infections in sub-Saharan Africa. (отвара нови прозор)

Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I

Извор‎: Transfusion 2010;50(2):433-42.

Индекс‎: PubMed 19843290

DOI‎: 10.1111/j.1537-2995.2009.002402.x

https://www.ncbi.nlm.nih.gov/pubmed/19843290 (отвара нови прозор)

Association between length of storage of red blood cell units and outcome of critically ill children: a prospective observational study. (отвара нови прозор)

Karam O, Tucci M, Bateman ST, Ducruet T, Spinella PC, Randolph AG, Lacroix J.

Извор‎: Crit Care 2010;14(2):R57.

Индекс‎: PubMed 20377853

DOI‎: 10.1186/cc8953

https://www.ncbi.nlm.nih.gov/pubmed/20377853 (отвара нови прозор)

Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. (отвара нови прозор)

Kirchhoff LV, Paredes P, Lomelí-Guerrero A, Paredes-Espinoza M, Ron-Guerrero CS, Delgado-Mejía M, Peña-Muñoz JG

Извор‎: Transfusion 2006;46(2):298-304.

Индекс‎: PubMed 16441610

DOI‎: 10.1111/j.1537-2995.2006.00715.x

https://www.ncbi.nlm.nih.gov/pubmed/16441610 (отвара нови прозор)

Adverse outcomes of blood transfusion in children: analysis of UK reports to the serious hazards of transfusion scheme 1996-2005. (отвара нови прозор)

Stainsby D, Jones H, Wells AW, Gibson B, Cohen H; SHOT Steering Group.

Извор‎: Br J Haematol 2008;141(1):73-9.

Индекс‎: PubMed 18324969

DOI‎: 10.1111/j.1365-2141.2008.07022.x

https://www.ncbi.nlm.nih.gov/pubmed/18324969 (отвара нови прозор)

Emerging infectious disease agents and their potential threat to transfusion safety. (отвара нови прозор)

Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY.

Извор‎: Transfusion 2009;49 Suppl 2:1S-29S.

Индекс‎: PubMed 19686562

DOI‎: 10.1111/j.1537-2995.2009.02279.x

https://www.ncbi.nlm.nih.gov/pubmed/19686562 (отвара нови прозор)

Analysis of pediatric adverse reactions to transfusions. (отвара нови прозор)

Vossoughi S, Perez G, Whitaker BI, Fung MK, Stotler B

Извор‎: Transfusion 2018;58(1):60-9.

Индекс‎: PubMed 28948619

DOI‎: 10.1111/trf.14359

https://www.ncbi.nlm.nih.gov/pubmed/28948619 (отвара нови прозор)